Cargando…
B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)
Autores principales: | Mueller, C, Scholer, A, Martina, B, Marsch, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099872/ http://dx.doi.org/10.1186/cc2752 |
Ejemplares similares
-
Andreas F Widmer for the Basel infection control team
por: Widmer, AF
Publicado: (2011) -
Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005) -
A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011) -
Time course of dyspnea evolution in the emergency department: results from the URGENT dyspnea survey
por: Tavares, M, et al.
Publicado: (2009) -
Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
por: Hoffmann, U, et al.
Publicado: (2004)